Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
China Biologic Products has been named to the 2009 list...
PPD, Inc., a US-based CRO, agreed to acquire...
PPD, Inc. will acquire BioDuro, a preclinical CRO, as a...
Merck KGaA of Germany will conduct a multi-national Phase...
PPD, Inc. has opened a vaccine clinical research center...
Roche will cut 4,800 jobs over the next two years as part...
The Institute of Biophysics, a division of the Chinese...
Boehringer Ingelheim has completed a $95 million...
Hua Medicine of Shanghai announced it will start a Phase...
Crown Bioscience, a US-China preclinical CRO with a focus...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
